Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Roman Chlibek
    Professor
    Department of Epidemiology
    University of Defence
    Czech Republic
    roman.chlibek@unob.cz
    JVI

    Research Interest: Infection diseases prevention, epidemiology of infectious diseases, vaccination, vaccines, travel and tropical medicine.

    More Info.
    Farhid Hemmatzadeh
    Senior Lecturer in Virology
    The University of Adelaide
    Australia
    farhid.hemmatzadeh@adelaide.edu.au
    JVI

    Research Interest: Molecular epidemiology, Development of diagnostic tests for viral disease, Cell culture, Bioinformatics.

    More Info.
    Vincent C Lombardi
    Assistant Professor
    University of Nevada
    USA
    vlombardi@medicine.nevada.edu
    JVI

    Research Interest: Virology/Microbiology, Biochemistry, Clinical Diagnostics, Molecular Biology, Protein Chemistry.

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    salvatore.chirumbolo@univr.it
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    andreaposcia83@gmail.com
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Julie Bouckaert
    Researcher
    Computational Molecular Systems Biology
    Lille University of Science and Technology
    France
    julie.bouckaert@univ-lille1.fr
    JVI

    Research Interest: Structure-to-function relationships of microbial lectins Structural study of multivalent protein-carbohydrate interactions Analysis of differential glycosylation and bacterial infection pathology during metabolic imbalance Structure-based design of anti-bacterial and anti-fungal drugs.

    More Info.
    Ting Wang
    Professor, School of Pharmacy
    Anhui Medical University
    China
    twangcn@hotmail.com
    JVI

    Research Interest: Nanoparticles, liposomes, solid lipid naonparticles, and anhydrous reverse micelles, drug/vaccine carriers, freeze-drying of pharmaceutics, design, carrying out and analysis of in vivo tests, separation and purification of chemicals, extraction and analysis of therapeutic.

    More Info.
    Yadong Zheng
    Lanzhou Veterinary Research Institute
    Chinese Academy of Agricultural Sciences
    China
    zhengyadong@caas.cn
    JVI

    Research Interest: Vaccine, innate immunity, parasite-host interaction.

    More Info.
    David Allen Reardon
    Professor
    Cancer Institute
    Harvard Cancer Center
    USA
    david_reardon@dfci.harvard.edu
    JVI

    Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

    More Info.
    Shih-Jen Liu
    Associate Investigator
    National Health Research Institutes
    Taiwan
    levent@nhri.org.tw
    JVI

    Research Interest: Currently, his studies focus on the two major directions. The first one is to study the innate receptor TLR and NLR ligands as adjuvant for CTL epitope-based vaccines to treat cancer and the adjuvant effect on the modulation of immune responses will be studied.

    More Info.
    Simon Blank
    Center of Allergy and Environment
    Technical University of Munich
    Germany
    simon.blank@tum.de
    JVI

    Research Interest: Allergy, Allergens, Carbohydrates, cross-reactive carbohydrate deteminants
    Immunomodulation, Antibody engineering, Molecule design, Molecular biology and biochemistry
    Recombinant technologies.

    More Info.
    Suh-Chin Wu
    Professor
    Institute of Biotechnology
    National Tsing Hua University
    Taiwan
    scwu@life.nthu.edu.tw
    JVI

    Research Interest: Biotechnology, Vaccines, Vaccine Development, Virology, Viral Vaccines.

    More Info.
    Guoyun Chen
    Assistant Professor
    Department of Pediatrics
    University of Tennessee Health Science Center
    USA
    GChen@childrensnational.org
    JVI

    Research Interest: Self-nonself discrimination in innate immunity, Host-pathogen interactions Autoimmune diseases.

    More Info.
    Kuo C SHENG
    Research Fellow
    Griffith University
    Australia
    kuosheng@mail.com
    JVI

    Research Interest: Cancer immunology, vaccines, cancer, antigen-presenting cells and viral immunology.

    More Info.
    Pele Choi-Sing Chong
    Founder of Vaccine Research and Development Center
    National Institute of Infectious Diseases and Vaccinology
    Taiwan
    pelechong@nhri.org.tw
    JVI

    Research Interest: Protein Engineering, Adjuvant and Vaccine Delivery Systems, Vaccinology, cGMP Quality Management, Immunology.

    More Info.
    View more
    mendeley

    Nano-chemistry and Bio-conjugation with perspectives on the design of Nano-Immune platforms, vaccines and new combinatorial treatments

    DOI Logo 10.17352/jvi.000047

    Published On: December 13, 2021 | Pages: 049 - 056

    Author(s): Luna R Gomez Palacios, Sofia Martinez, Cecilia Tettamanti, Daniela Quinteros and A Guillermo Bracamonte*
    Abstract View Full Article View
    mendeley

    Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a Transdermal Microneedle System

    DOI Logo 10.17352/jvi.000046

    Published On: December 13, 2021 | Pages: 041 - 048

    Author(s): Mahmoud Ameri*, Hayley Lewis and Joe Nguyen
    Abstract View Full Article View
    mendeley

    Japanese Encephalitis (JE): A curse for people living in Uttar Pradesh, India

    DOI Logo 10.17352/jvi.000045

    Published On: October 04, 2021 | Pages: 036 - 040

    Author(s): Jay Prakash Patel*, Kusum Verma and Vijeta Singh
    Abstract View Full Article View    
    mendeley

    COVID-19, nursing publication and the future of nursing research infection

    DOI Logo 10.17352/jvi.000044

    Published On: July 24, 2021 | Pages: 034 - 035

    Author(s): Salam Banihani*
    Abstract View Full Article View    
    mendeley

    COVID-19 IGG better than PCR for the green pass

    DOI Logo 10.17352/jvi.000043

    Published On: July 20, 2021 | Pages: 033 - 033

    Author(s): Damsa Cristian* and Damsa Tomas
    Abstract View Full Article View    
    mendeley

    Saliva as a source of antibodies for MMR vaccine screening in teenagers

    DOI Logo 10.17352/jvi.000042

    Published On: May 24, 2021 | Pages: 027 - 032

    Author(s): Barbara Fialho Carvalho Sampaio*, Luciana Regina Meireles and Heitor Franco de Andrade
    Abstract View Full Article View    
    mendeley

    Convenience and economic benefit of early one-shot Mycoplasma hyopneumoniae vaccination at 3 days of age in a commercial sow farm

    DOI Logo 10.17352/jvi.000041

    Published On: May 24, 2021 | Pages: 020 - 026

    Author(s): Frédéric Vangroenweghe*
    Abstract View Full Article View    
    mendeley

    Impact of the COVID-19 pandemic on work capacities of researchers: An overlooked problem

    DOI Logo 10.17352/jvi.000040

    Published On: May 21, 2021 | Pages: 014 - 019

    Author(s): Ferdinando D’Amico, Didier Mainard, Cedric Baumann and Laurent Peyrin-Biroulet*
    Abstract View Full Article View    
    mendeley

    A Commentary: The pandemic is calling for effective personal protection through innate immunological boosting

    DOI Logo 10.17352/jvi.000039

    Published On: May 21, 2021 | Pages: 009 - 013

    Author(s): Chung-Lap Ben Chan, Chun-kwok Wong and Ping-chung Leung*
    Abstract View Full Article View    
    mendeley

    Vaccine development and delivery strategies – A glimpse

    DOI Logo 10.17352/jvi.000038

    Published On: February 20, 2021 | Pages: 004 - 008

    Author(s): Rashmi P* and Madhavi BLR
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on JVI